APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Losartan Potassium Hydrochlorothiazide Tablet

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Losartan Potassium Hydrochlorothiazide Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174009050322 December 2025189 pages

Choose your research edition.

Industry ResearchLosartan Potassium Hydrochlorothiazide Tablet Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Losartan Potassium Hydrochlorothiazide Tablet Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Losartan Potassium Hydrochlorothiazide Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Losartan Potassium Hydrochlorothiazide Tablet Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Losartan Potassium Hydrochlorothiazide Tablet Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Losartan Potassium Hydrochlorothiazide Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Losartan Potassium Hydrochlorothiazide Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Losartan Potassium Hydrochlorothiazide Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Losartan Potassium Hydrochlorothiazide Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Losartan Potassium Hydrochlorothiazide Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Losartan Potassium Hydrochlorothiazide Tablet include Zhejiang NuoDe Pharmaceutical, Zhejiang Huahai Pharmaceutical, Dawnrays Pharmaceutical, Shandong XinYi Pharmaceutical, Lepu Medical Technology (Beijing), TIANJIN PHARMACEUTICAL DA REN TANG GROUP, Beijing Twinluck, Beijing Winsunny Pharmaceutical and Cozaar, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Losartan Potassium Hydrochlorothiazide Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Losartan Potassium Hydrochlorothiazide Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Losartan Potassium Hydrochlorothiazide Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Losartan Potassium Hydrochlorothiazide Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Losartan Potassium Hydrochlorothiazide Tablet Segment by Company

Zhejiang NuoDe Pharmaceutical

Zhejiang Huahai Pharmaceutical

Dawnrays Pharmaceutical

Shandong XinYi Pharmaceutical

Lepu Medical Technology (Beijing)

TIANJIN PHARMACEUTICAL DA REN TANG GROUP

Beijing Twinluck

Beijing Winsunny Pharmaceutical

Cozaar

Losartan Potassium Hydrochlorothiazide Tablet Segment by Type

50mg

100mg

Others

Losartan Potassium Hydrochlorothiazide Tablet Segment by Application

Elderly

Children

Adult

Losartan Potassium Hydrochlorothiazide Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Losartan Potassium Hydrochlorothiazide Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Losartan Potassium Hydrochlorothiazide Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Losartan Potassium Hydrochlorothiazide Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Losartan Potassium Hydrochlorothiazide Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Losartan Potassium Hydrochlorothiazide Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Losartan Potassium Hydrochlorothiazide Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Losartan Potassium Hydrochlorothiazide Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Losartan Potassium Hydrochlorothiazide Tablet Industry Trends Table 2. Losartan Potassium Hydrochlorothiazide Tablet Industry Drivers Table 3. Losartan Potassium Hydrochlorothiazide Tablet Industry Opportunities and Challenges Table 4. Losartan Potassium Hydrochlorothiazide Tablet Industry Restraints Table 5. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Manufacturers Table 9. Global Losartan Potassium Hydrochlorothiazide Tablet Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Losartan Potassium Hydrochlorothiazide Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Losartan Potassium Hydrochlorothiazide Tablet Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Losartan Potassium Hydrochlorothiazide Tablet Manufacturers, Product Type & Application Table 13. Global Losartan Potassium Hydrochlorothiazide Tablet Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Losartan Potassium Hydrochlorothiazide Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50mg Table 17. Major Manufacturers of 100mg Table 18. Major Manufacturers of Others Table 19. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Type (2021-2026) & (k units) Table 21. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Type (2027-2032) & (k units) Table 22. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Type (2021-2026) Table 23. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Type (2027-2032) Table 24. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Type (2021-2026) & (k units) Table 26. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Type (2027-2032) & (k units) Table 27. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Type (2021-2026) Table 28. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Elderly Table 30. Major Manufacturers of Children Table 31. Major Manufacturers of Adult Table 32. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Application (2021-2026) & (k units) Table 34. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Application (2027-2032) & (k units) Table 35. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Application (2021-2026) Table 36. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Application (2027-2032) Table 37. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Application (2021-2026) & (k units) Table 39. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Application (2027-2032) & (k units) Table 40. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Application (2021-2026) Table 41. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Application (2027-2032) Table 42. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Region (2021-2026) & (k units) Table 44. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Region (2021-2026) Table 45. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Losartan Potassium Hydrochlorothiazide Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2026) & (k units) Table 49. North America Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2027-2032) & (k units) Table 50. Europe Losartan Potassium Hydrochlorothiazide Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2026) & (k units) Table 52. Europe Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2027-2032) & (k units) Table 59. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Region (2021-2026) Table 63. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Region (2027-2032) Table 64. Zhejiang NuoDe Pharmaceutical Company Information Table 65. Zhejiang NuoDe Pharmaceutical Business Overview Table 66. Zhejiang NuoDe Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Zhejiang NuoDe Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio Table 68. Zhejiang NuoDe Pharmaceutical Recent Development Table 69. Zhejiang Huahai Pharmaceutical Company Information Table 70. Zhejiang Huahai Pharmaceutical Business Overview Table 71. Zhejiang Huahai Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Zhejiang Huahai Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio Table 73. Zhejiang Huahai Pharmaceutical Recent Development Table 74. Dawnrays Pharmaceutical Company Information Table 75. Dawnrays Pharmaceutical Business Overview Table 76. Dawnrays Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Dawnrays Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio Table 78. Dawnrays Pharmaceutical Recent Development Table 79. Shandong XinYi Pharmaceutical Company Information Table 80. Shandong XinYi Pharmaceutical Business Overview Table 81. Shandong XinYi Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Shandong XinYi Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio Table 83. Shandong XinYi Pharmaceutical Recent Development Table 84. Lepu Medical Technology (Beijing) Company Information Table 85. Lepu Medical Technology (Beijing) Business Overview Table 86. Lepu Medical Technology (Beijing) Losartan Potassium Hydrochlorothiazide Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Lepu Medical Technology (Beijing) Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio Table 88. Lepu Medical Technology (Beijing) Recent Development Table 89. TIANJIN PHARMACEUTICAL DA REN TANG GROUP Company Information Table 90. TIANJIN PHARMACEUTICAL DA REN TANG GROUP Business Overview Table 91. TIANJIN PHARMACEUTICAL DA REN TANG GROUP Losartan Potassium Hydrochlorothiazide Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. TIANJIN PHARMACEUTICAL DA REN TANG GROUP Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio Table 93. TIANJIN PHARMACEUTICAL DA REN TANG GROUP Recent Development Table 94. Beijing Twinluck Company Information Table 95. Beijing Twinluck Business Overview Table 96. Beijing Twinluck Losartan Potassium Hydrochlorothiazide Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Beijing Twinluck Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio Table 98. Beijing Twinluck Recent Development Table 99. Beijing Winsunny Pharmaceutical Company Information Table 100. Beijing Winsunny Pharmaceutical Business Overview Table 101. Beijing Winsunny Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Beijing Winsunny Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio Table 103. Beijing Winsunny Pharmaceutical Recent Development Table 104. Cozaar Company Information Table 105. Cozaar Business Overview Table 106. Cozaar Losartan Potassium Hydrochlorothiazide Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Cozaar Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio Table 108. Cozaar Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Losartan Potassium Hydrochlorothiazide Tablet Distributors List Table 112. Losartan Potassium Hydrochlorothiazide Tablet Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Losartan Potassium Hydrochlorothiazide Tablet Product Image Figure 2. Global Losartan Potassium Hydrochlorothiazide Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Losartan Potassium Hydrochlorothiazide Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Losartan Potassium Hydrochlorothiazide Tablet Sales (2021-2032) & (k units) Figure 5. Global Losartan Potassium Hydrochlorothiazide Tablet Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Losartan Potassium Hydrochlorothiazide Tablet Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50mg Image Figure 9. 100mg Image Figure 10. Others Image Figure 11. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Type (2021-2032) Figure 14. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Type (2021-2032) Figure 17. Elderly Image Figure 18. Children Image Figure 19. Adult Image Figure 20. Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Application (2021-2032) Figure 23. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Application (2021-2032) Figure 26. North America Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Country (2021-2032) Figure 28. U.S. Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Country (2021-2032) Figure 33. Germany Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Country (2021-2032) Figure 40. China Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Country (2021-2032) Figure 48. Brazil Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Losartan Potassium Hydrochlorothiazide Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Losartan Potassium Hydrochlorothiazide Tablet Revenue (2021-2032) & (US$ Million) Figure 59. North America Losartan Potassium Hydrochlorothiazide Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Losartan Potassium Hydrochlorothiazide Tablet Revenue (2021-2032) & (US$ Million) Figure 61. Europe Losartan Potassium Hydrochlorothiazide Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Losartan Potassium Hydrochlorothiazide Tablet Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Losartan Potassium Hydrochlorothiazide Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Losartan Potassium Hydrochlorothiazide Tablet Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Losartan Potassium Hydrochlorothiazide Tablet Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
  • Others
Applications
  • Elderly
  • Children
  • Adult
Companies covered
  • Zhejiang NuoDe Pharmaceutical
  • Zhejiang Huahai Pharmaceutical
  • Dawnrays Pharmaceutical
  • Shandong XinYi Pharmaceutical
  • Lepu Medical Technology (Beijing)
  • TIANJIN PHARMACEUTICAL DA REN TANG GROUP
  • Beijing Twinluck
  • Beijing Winsunny Pharmaceutical
  • Cozaar

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Losartan Potassium Hydrochlorothiazide Tablet Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Losartan Potassium Hydrochlorothiazide Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Losartan Potassium Hydrochlorothiazide Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Losartan Potassium Hydrochlorothiazide Tablet Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Losartan Potassium Hydrochlorothiazide Tablet Market Dynamics
  1. 2.1 Losartan Potassium Hydrochlorothiazide Tablet Industry Trends
  2. 2.2 Losartan Potassium Hydrochlorothiazide Tablet Industry Drivers
  3. 2.3 Losartan Potassium Hydrochlorothiazide Tablet Industry Opportunities and Challenges
  4. 2.4 Losartan Potassium Hydrochlorothiazide Tablet Industry Restraints
3 Losartan Potassium Hydrochlorothiazide Tablet Market by Manufacturers
  1. 3.1 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Manufacturers (2021-2026)
  3. 3.3 Global Losartan Potassium Hydrochlorothiazide Tablet Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Losartan Potassium Hydrochlorothiazide Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Losartan Potassium Hydrochlorothiazide Tablet Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Losartan Potassium Hydrochlorothiazide Tablet Manufacturers, Product Type & Application
  7. 3.7 Global Losartan Potassium Hydrochlorothiazide Tablet Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Losartan Potassium Hydrochlorothiazide Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Losartan Potassium Hydrochlorothiazide Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Losartan Potassium Hydrochlorothiazide Tablet Tier 1, Tier 2, and Tier 3
4 Losartan Potassium Hydrochlorothiazide Tablet Market by Type
  1. 4.1 Losartan Potassium Hydrochlorothiazide Tablet Type Introduction
  2. 4.1.1 50mg
  3. 4.1.2 100mg
  4. 4.1.3 Others
  5. 4.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Type
  6. 4.2.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Type (2021-2032)
  8. 4.2.3 Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Type (2021-2032)
  9. 4.3 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Type
  10. 4.3.1 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Type (2021-2032)
  12. 4.3.3 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Type (2021-2032)
5 Losartan Potassium Hydrochlorothiazide Tablet Market by Application
  1. 5.1 Losartan Potassium Hydrochlorothiazide Tablet Application Introduction
  2. 5.1.1 Elderly
  3. 5.1.2 Children
  4. 5.1.3 Adult
  5. 5.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Application
  6. 5.2.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Application (2021-2032)
  8. 5.2.3 Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Application (2021-2032)
  9. 5.3 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Application
  10. 5.3.1 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Application (2021-2032)
  12. 5.3.3 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Application (2021-2032)
6 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Region
  1. 6.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Region (2021-2026)
  4. 6.2.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Losartan Potassium Hydrochlorothiazide Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Losartan Potassium Hydrochlorothiazide Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Region
  1. 7.1 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Region
  2. 7.1.1 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Region (2021-2026)
  4. 7.1.3 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Region (2027-2032)
  5. 7.1.4 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Losartan Potassium Hydrochlorothiazide Tablet Revenue (2021-2032)
  8. 7.2.2 North America Losartan Potassium Hydrochlorothiazide Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Losartan Potassium Hydrochlorothiazide Tablet Revenue (2021-2032)
  11. 7.3.2 Europe Losartan Potassium Hydrochlorothiazide Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Losartan Potassium Hydrochlorothiazide Tablet Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Losartan Potassium Hydrochlorothiazide Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang NuoDe Pharmaceutical
  2. 8.1.1 Zhejiang NuoDe Pharmaceutical Company Information
  3. 8.1.2 Zhejiang NuoDe Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang NuoDe Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang NuoDe Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
  6. 8.1.5 Zhejiang NuoDe Pharmaceutical Recent Developments
  7. 8.2 Zhejiang Huahai Pharmaceutical
  8. 8.2.1 Zhejiang Huahai Pharmaceutical Company Information
  9. 8.2.2 Zhejiang Huahai Pharmaceutical Business Overview
  10. 8.2.3 Zhejiang Huahai Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Huahai Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
  12. 8.2.5 Zhejiang Huahai Pharmaceutical Recent Developments
  13. 8.3 Dawnrays Pharmaceutical
  14. 8.3.1 Dawnrays Pharmaceutical Company Information
  15. 8.3.2 Dawnrays Pharmaceutical Business Overview
  16. 8.3.3 Dawnrays Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dawnrays Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
  18. 8.3.5 Dawnrays Pharmaceutical Recent Developments
  19. 8.4 Shandong XinYi Pharmaceutical
  20. 8.4.1 Shandong XinYi Pharmaceutical Company Information
  21. 8.4.2 Shandong XinYi Pharmaceutical Business Overview
  22. 8.4.3 Shandong XinYi Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shandong XinYi Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
  24. 8.4.5 Shandong XinYi Pharmaceutical Recent Developments
  25. 8.5 Lepu Medical Technology (Beijing)
  26. 8.5.1 Lepu Medical Technology (Beijing) Company Information
  27. 8.5.2 Lepu Medical Technology (Beijing) Business Overview
  28. 8.5.3 Lepu Medical Technology (Beijing) Losartan Potassium Hydrochlorothiazide Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lepu Medical Technology (Beijing) Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
  30. 8.5.5 Lepu Medical Technology (Beijing) Recent Developments
  31. 8.6 TIANJIN PHARMACEUTICAL DA REN TANG GROUP
  32. 8.6.1 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Company Information
  33. 8.6.2 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Business Overview
  34. 8.6.3 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Losartan Potassium Hydrochlorothiazide Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
  36. 8.6.5 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Recent Developments
  37. 8.7 Beijing Twinluck
  38. 8.7.1 Beijing Twinluck Company Information
  39. 8.7.2 Beijing Twinluck Business Overview
  40. 8.7.3 Beijing Twinluck Losartan Potassium Hydrochlorothiazide Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Twinluck Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
  42. 8.7.5 Beijing Twinluck Recent Developments
  43. 8.8 Beijing Winsunny Pharmaceutical
  44. 8.8.1 Beijing Winsunny Pharmaceutical Company Information
  45. 8.8.2 Beijing Winsunny Pharmaceutical Business Overview
  46. 8.8.3 Beijing Winsunny Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Beijing Winsunny Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
  48. 8.8.5 Beijing Winsunny Pharmaceutical Recent Developments
  49. 8.9 Cozaar
  50. 8.9.1 Cozaar Company Information
  51. 8.9.2 Cozaar Business Overview
  52. 8.9.3 Cozaar Losartan Potassium Hydrochlorothiazide Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cozaar Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
  54. 8.9.5 Cozaar Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Losartan Potassium Hydrochlorothiazide Tablet Value Chain Analysis
  2. 9.1.1 Losartan Potassium Hydrochlorothiazide Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Losartan Potassium Hydrochlorothiazide Tablet Production Mode & Process
  6. 9.2 Losartan Potassium Hydrochlorothiazide Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Losartan Potassium Hydrochlorothiazide Tablet Distributors
  9. 9.2.3 Losartan Potassium Hydrochlorothiazide Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst